- $500 MnWorld market, 2023
- $1.2 BnProjected, 2033
- 9%Growth a year (CAGR)
- 77Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$210 Mn
7% a year · 42% of the world -
2
China
$40 Mn
10.5% a year · 8% of the world -
3
Canada
$40 Mn
9% a year · 8% of the world -
4
Japan
$31 Mn
9.5% a year · 6.2% of the world -
5
Germany
$18 Mn
7.2% a year · 3.7% of the world -
6
France
$14 Mn
8% a year · 2.8% of the world -
7
UK
$13 Mn
7% a year · 2.6% of the world -
8
Brazil
$13 Mn
10% a year · 2.5% of the world -
9
Italy
$12 Mn
8.5% a year · 2.4% of the world -
10
Ecuador
$10 Mn
9.6% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Coenzyme Q10 by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $500 Mn | $1.2 Bn | 9% | – | 77 | Report on Coenzyme Q10 in Global |
| North America | $250 Mn | $540 Mn | 8% | 50% | 23 | Report on Coenzyme Q10 in North America |
| APAC | $105 Mn | $279 Mn | 10.3% | 21% | 11 | Report on Coenzyme Q10 in APAC |
| Europe | $95 Mn | $200 Mn | 7.7% | 19% | 11 | Report on Coenzyme Q10 in Europe |
| Latin America | $23 Mn | $58 Mn | 10% | 4.5% | 0 | Report on Coenzyme Q10 in Latin America |
| Middle East | $20 Mn | $52 Mn | 10% | 4% | 0 | Report on Coenzyme Q10 in Middle East |
| Africa | $8 Mn | $20 Mn | 10.5% | 1.5% | 11 | Report on Coenzyme Q10 in Africa |
| US |
$210 Mn | $413 Mn | 7% | 42% | 21 | Report on Coenzyme Q10 in US |
| China |
$40 Mn | $109 Mn | 10.5% | 8% | 7 | Report on Coenzyme Q10 in China |
| Canada |
$40 Mn | $95 Mn | 9% | 8% | 3 | Report on Coenzyme Q10 in Canada |
| Japan |
$31 Mn | $77 Mn | 9.5% | 6.2% | 1 | Report on Coenzyme Q10 in Japan |
| Germany |
$18 Mn | $37 Mn | 7.2% | 3.7% | 2 | Report on Coenzyme Q10 in Germany |
| France |
$14 Mn | $30 Mn | 8% | 2.8% | 2 | Report on Coenzyme Q10 in France |
| UK |
$13 Mn | $26 Mn | 7% | 2.6% | 1 | Report on Coenzyme Q10 in UK |
| Brazil |
$13 Mn | $32 Mn | 10% | 2.5% | 0 | Report on Coenzyme Q10 in Brazil |
| Italy |
$12 Mn | $27 Mn | 8.5% | 2.4% | 7 | Report on Coenzyme Q10 in Italy |
| Ecuador |
$10 Mn | $25 Mn | 9.6% | 2% | 0 | Report on Coenzyme Q10 in Ecuador |
 Spain |
$10 Mn | $21 Mn | 8% | 1.9% | 1 | Report on Coenzyme Q10 in Spain |
 India |
$9 Mn | $28 Mn | 12% | 1.8% | 0 | Report on Coenzyme Q10 in India |
 Saudi Arabia |
$9 Mn | $23 Mn | 10.5% | 1.7% | 0 | Report on Coenzyme Q10 in Saudi Arabia |
 Mexico |
$8 Mn | $18 Mn | 9.3% | 1.5% | 0 | Report on Coenzyme Q10 in Mexico |
 Australia |
$6 Mn | $16 Mn | 10.5% | 1.2% | 0 | Report on Coenzyme Q10 in Australia |
 South Africa |
$3 Mn | $9 Mn | 10.2% | 0.7% | 0 | Report on Coenzyme Q10 in South Africa |
 UAE |
$3 Mn | $7 Mn | 10% | 0.5% | 0 | Report on Coenzyme Q10 in UAE |
 Egypt |
$1 Mn | $4 Mn | 10.5% | 0.3% | 11 | Report on Coenzyme Q10 in Egypt |
 Philippines |
$1 Mn | $3 Mn | 9.5% | 0.2% | 0 | Report on Coenzyme Q10 in Philippines |
 Hong Kong |
$1 Mn | $2 Mn | 10% | 0.2% | 2 | Report on Coenzyme Q10 in Hong Kong |
 Malaysia |
$1 Mn | $2 Mn | 9.2% | 0.2% | 0 | Report on Coenzyme Q10 in Malaysia |
 Singapore |
$1 Mn | $2 Mn | 9.6% | 0.1% | 0 | Report on Coenzyme Q10 in Singapore |
 Thailand |
$1 Mn | $2 Mn | 9.3% | 0.1% | 1 | Report on Coenzyme Q10 in Thailand |
 Kenya |
$0 Mn | $1 Mn | 10.1% | 0.1% | 0 | Report on Coenzyme Q10 in Kenya |
 New Zealand |
– | – | – | – | 0 | Report on Coenzyme Q10 in New Zealand |
 Russia |
– | – | – | – | 1 | Report on Coenzyme Q10 in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 4,006 papers since 2021
- Reply to "Caution Needed Regarding Conclusions of Meta-Analysis of Coenzyme Q10 as Treatment for Depressive Symptoms". Journal of clinical psychopharmacology, 2026
- URBANOME: an exposome-based framework linking urban interventions to molecular, health, and policy-relevant outcomes. Human genomics, 2026
- The effect of minocycline on the gut microbiome in individuals with alcohol use disorder and healthy controls. bioRxiv : the preprint server for biology, 2026
- YY1 transcriptionally activates PMVK to promote radioresistance by inhibiting ferroptosis in lung adenocarcinoma. Molecular genetics and genomics : MGG, 2026
- Amifostine improves goat sperm quality and fertility during hypothermic storage by modulating mitochondrial energy metabolism. Animal reproduction science, 2026
Compare Coenzyme Q10 side by side
Key companies in Coenzyme Q10
DSM Nutritional Products AG
Hwail Pharmaceutical CO.,Ltd
Gnosis
Kaneka Corporation
KYOWA Hakko U.S.A Inc
Mitsubishi Gas Chemical Company, INC
Nisshin Seifun Group Inc
PharmaEssentia Corporation
ZMC-USA LLC
Kaneka Corporation
KYOWA Hakko U.S.A Inc
Mitsubishi Gas Chemical Company, INC
Nisshin Seifun Group Inc
PharmaEssentia Corporation
ZMC-USA LLC
Quick answers
How big is the Coenzyme Q10 market?
The world Coenzyme Q10 market was worth about $500 Mn in 2023 and is projected to reach $1.2 Bn by 2033, growing 9% a year (CAGR).
Which country has the largest Coenzyme Q10 market?
The US is the largest of the 24 countries we cover, at $210 Mn in 2023. India grows fastest, at 12% a year.
How many clinical trials are running in Coenzyme Q10?
ClinicalTrials.gov lists 77 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Coenzyme Q10?
PubMed lists about 4,006 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.